Actively Recruiting
Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".
Led by Nantes University Hospital · Updated on 2025-11-14
114
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prematurity is associated with an increased risk of developing cardiovascular and metabolic disturbances in adulthood. It has been demonstrated that the body composition of children born prematurely is different from that of children born under term with a deficit in fat free mass. It can thus be wondered if this excessive adiposity does or does not predict the risk of insulin resistance in adulthood. Children born prematurely, with a body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol, and now aged between 8 and 14 years, will be included in the INFANTPOD protocol. Analysis of body composition, insulin resistance, renal function, pulse wave velocity, eating behaviour and of physical activity will be performed.
CONDITIONS
Official Title
Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children hospitalized at the Nantes University Hospital in the neonatal period
- Body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol
- Born prematurely (under 35 weeks of amenorrhea)
- Included in the Lift cohort with follow-up up to 7 years
- Aged between 8 and 14 years at inclusion
You will not qualify if you...
- Children with isolated metabolic diseases such as insulin-dependent diabetes or endocrine diseases like Cushing's or hypothyroidism
- Age 15 years or older
- Chromosomal anomalies
- Contraindications for BOP-POD measurement such as ventilatory support, continuous parenteral feeding, or elimination stoma
- Refusal of either parent or child
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nantes University Hospital
Nantes, France, 44600
Actively Recruiting
Research Team
A
Anne FRONDAS, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here